UPMC Enterprises, the medical technology investment arm of UPMC, has purchased interest in RxAnte, a company that uses analytics to predict how patients will adhere to the medications they’re prescribed.
Read more on Pittsburgh Business Times.
Pittsburgh Business Times: UPMC Enterprises invests in prescription analytics company RxAnte
Related Resources
More Resources
06.29.20
RxAnte and Mosaic Pharmacy Service Co-Present: Caring for Medically Complex and Vulnerable Members
Blog Post
On May 28 in conjunction with the PQA 2020 Annual Meeting, RxAnte and Mosaic Pharmacy Service presented an Innovation Theater focused on the role of a comprehensive pharmacy service in addressing the needs of medically complex and vulnerable Medicare members.
04.08.20
Enhancing the Role of Pharmacy: Pairing Claims with Qualitative Member Data to Improve Both Patient Care and Outcomes
Whitepaper
In our latest piece, we discuss the challenges of medication adherence for MAPD plans and their member populations; the current approaches leveraged to effectively intervene and encourage better medication use; and the gap that exists to reach and support vulnerable and medically complex Medicare members.
01.29.20
A Roadmap to Improving Your Stars Strategy in 2020
Blog Post
Heading into 2020, we often see health plans use the same strategy to improve member adherence; however, executing a plan with unchanged tactics can result in these familiar challenges: